Ahead Biocomputing was selected as a winner of the Toshiba "OPEN INNOVATION PROGRAM 2022" in the category of business planning with the SQBM+™ Simulated Bifurcation Machines (SBM) developed by Toshiba.
The "Toshiba OPEN INNOVATION PROGRAM 2022" is a program that provides support for accelerating the commercialization of companies applying for the program through collaboration with Toshiba Group, utilizing Toshiba Group's business assets and advanced technologies. Continuing from last year, we are participating in the business development category utilizing the SQBM+™ (an Ising machine that solves large-scale combinatorial optimization problems at high speed, born from research into pseudo-quantum based on the principles of quantum mechanics). We will conduct a series of demonstrations and other experiments toward the presentation of the results at the end of September 2022 and will consider the business development of this technology.
「Toshiba OPEN INNOVATION PROGRAM 2022」参加企業9社と協業検討を開始 | ニュース | 東芝 (in Japanese)
https://www.global.toshiba/jp/news/corporate/2022/08/news-20220809-01.htmlToshiba Open INNOVATION PROGRAM 2022 (in Japanese)
https://growth.creww.me/dadee07c-a0ca-11ec-bfed-ed6acc2b5168.htmlQuantum-Inspired Optimization Solutions SQBM+ | TOSHIBA DIGITAL SOLUTIONS CORPORATION
https://www.global.toshiba/ww/products-solutions/ai-iot/sbm.htmlWe made a presentation of the achievements on the “Toshiba OPEN INNOVATION PROGRAM 2021” – Ahead Biocomputing, Co. Ltd.
https://ahead-biocomputing.co.jp/en/20210927-1/
